149 related articles for article (PubMed ID: 7379369)
1. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
Zimmerman L; Baldesten A; Bergström J; Fürst P
Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
[TBL] [Abstract][Full Text] [Related]
2. Determination of endogenous middle molecules in normal and uremic body fluids.
Fürst P; Zimmerman L; Bergström J
Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
[TBL] [Abstract][Full Text] [Related]
3. Characterization of middle molecule compounds.
Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
[TBL] [Abstract][Full Text] [Related]
4. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
Li G; Chu J; Liu X; Yuan Z
Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
[TBL] [Abstract][Full Text] [Related]
5. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
Gordon A; Berström J; Fürst P; Zimmerman L
Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
[No Abstract] [Full Text] [Related]
6. Separation, isolation and amino acid composition of uremic peptides.
Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S
Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692
[TBL] [Abstract][Full Text] [Related]
7. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)].
Cueille G
J Chromatogr; 1978 Jul; 146(1):55-65. PubMed ID: 670358
[TBL] [Abstract][Full Text] [Related]
8. Technical aspects on middle molecules: separation, isolation, and identification.
Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
[TBL] [Abstract][Full Text] [Related]
9. Characterization of sub-peak b4.2, middle molecule.
Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():28-32. PubMed ID: 7295091
[TBL] [Abstract][Full Text] [Related]
10. Plasma middle molecules in asymptomatic and "sick" uremic patients.
Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V
Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
[TBL] [Abstract][Full Text] [Related]
11. Analytical study for separation of middle molecules.
Saito A; Kanazawa I; Chung TG; Maeda K
Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxic properties of plasma fractions from uremic patients.
Delaporte C; Gros F; Jonsson C; Bergström J
Artif Organs; 1981; 4 Suppl():68-70. PubMed ID: 7295099
[TBL] [Abstract][Full Text] [Related]
13. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity?
Vanholder R; Van Laecke S; Glorieux G
J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708
[TBL] [Abstract][Full Text] [Related]
14. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
Asaba H; Alvestrand A; Bergström J; Fürst P; Yahiel V
Clin Nephrol; 1982 Feb; 17(2):90-5. PubMed ID: 7067171
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the analysis of uremic toxins by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2600-6. PubMed ID: 19083276
[TBL] [Abstract][Full Text] [Related]
16. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L
Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320
[No Abstract] [Full Text] [Related]
17. Separation and quantification of the "middle molecules" in uremia.
Chapman GV; Ward RA; Farrell PC
Kidney Int; 1980 Jan; 17(1):82-8. PubMed ID: 7374022
[TBL] [Abstract][Full Text] [Related]
18. Methodology for identification of serum middle molecules.
Buzio C; Montagna G; Calderini C; Manari A; Migone L
Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
Ringoir SM; van Landschoot N; de Smet R
Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
[TBL] [Abstract][Full Text] [Related]
20. Improved separation and quantification of the "middle molecule" b4-2 in uremia.
Faguer P; Man NK; Cueille G; Di Giulio S; Funck-Brentano JL
Clin Chem; 1983 Apr; 29(4):703-7. PubMed ID: 6831703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
